IN2014DN08394A - - Google Patents

Info

Publication number
IN2014DN08394A
IN2014DN08394A IN8394DEN2014A IN2014DN08394A IN 2014DN08394 A IN2014DN08394 A IN 2014DN08394A IN 8394DEN2014 A IN8394DEN2014 A IN 8394DEN2014A IN 2014DN08394 A IN2014DN08394 A IN 2014DN08394A
Authority
IN
India
Prior art keywords
cell responses
hiv
pathogen
toggle
cytokines
Prior art date
Application number
Inventor
Riol Marta Ruiz
Christian Brander
Javier Ibarrondo
Original Assignee
Esteve Labor Dr
Fundació Privada Inst De Recerca De La Sida Caixa
Institució Catalana De Recerca I Estudis Avançats
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr, Fundació Privada Inst De Recerca De La Sida Caixa, Institució Catalana De Recerca I Estudis Avançats filed Critical Esteve Labor Dr
Publication of IN2014DN08394A publication Critical patent/IN2014DN08394A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Abstract

The invention relates to a method and a diagnostic kit for monitoring HIV specific T cell responses and identifying subjects capable of controlling HIV progression or preventing HIV infection altogether. The method is based on the combined use of boosted flow cytometry and toggle peptides and can cover a vastly larger set of effector functions than standard assays. The method is also suitable to detect T cell responses of any desirable cytokine or combination of cytokines to any pathogen.
IN8394DEN2014 2012-03-23 2013-03-22 IN2014DN08394A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615038P 2012-03-23 2012-03-23
EP12382109 2012-03-23
PCT/EP2013/056110 WO2013139972A1 (en) 2012-03-23 2013-03-22 Method for monitoring hiv specific t cell responses

Publications (1)

Publication Number Publication Date
IN2014DN08394A true IN2014DN08394A (en) 2015-05-08

Family

ID=49221879

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8394DEN2014 IN2014DN08394A (en) 2012-03-23 2013-03-22

Country Status (9)

Country Link
US (1) US9709577B2 (en)
EP (1) EP2828656B1 (en)
JP (1) JP6272820B2 (en)
CN (1) CN104272108A (en)
CA (1) CA2868066C (en)
HK (1) HK1205264A1 (en)
IN (1) IN2014DN08394A (en)
MX (1) MX2014011484A (en)
WO (1) WO2013139972A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101777252B1 (en) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) Method for evaluating suppression ability of T cell for PRRSV infected-cells
KR101777256B1 (en) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) Method for evaluating cytotoxic ability of T cell for pathogen infected-cells
CN110308285B (en) * 2019-07-12 2022-07-26 中国人民解放军军事科学院军事医学研究院 Marker combination for predicting death from severe ionizing radiation injury
WO2023170189A1 (en) * 2022-03-09 2023-09-14 Fundacio Privada Institut De Recerca De La Sida-Caixa Boosted immune monitoring methods for assaying antigen-specific t cell responses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
US6656471B1 (en) * 1998-11-17 2003-12-02 Board Of Regents, The University Of Texas System HIV-specific T-cell induction
AU2002952548A0 (en) * 2002-11-08 2002-11-21 Cellestis Limited Diagnostic assay
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
EP1767937A1 (en) * 2005-09-27 2007-03-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method of diagnosis of tuberculosis related immune restoration syndrome (IRS)
DE602007008209D1 (en) * 2006-03-20 2010-09-16 St Vincents Hosp Sydney METHOD FOR DETECTING ANTIGEN-SPECIFIC OR MITOGENIC ACTIVATED T CELLS
WO2008127840A2 (en) * 2007-03-22 2008-10-23 University Of Iowa Research Foundation Flavivirus ns5a proteins for the treatment of hiv
US20090263828A1 (en) * 2008-04-16 2009-10-22 Franco Lori Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)
WO2010037408A1 (en) * 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
JP6401609B2 (en) * 2011-04-29 2018-10-10 セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． Tolerogenic synthetic nanocarriers that reduce antibody responses

Also Published As

Publication number Publication date
EP2828656A1 (en) 2015-01-28
US9709577B2 (en) 2017-07-18
WO2013139972A1 (en) 2013-09-26
MX2014011484A (en) 2015-09-23
EP2828656B1 (en) 2019-09-18
JP6272820B2 (en) 2018-01-31
JP2015513100A (en) 2015-04-30
CN104272108A (en) 2015-01-07
US20150057175A1 (en) 2015-02-26
CA2868066C (en) 2019-11-12
CA2868066A1 (en) 2013-09-26
HK1205264A1 (en) 2015-12-11

Similar Documents

Publication Publication Date Title
MX2018004206A (en) Methods for diagnosing infectious diseases using adsorption media.
PH12018500558B1 (en) Device and system for analyzing a sample, particularly blood, as well as methods of using the same
EP2708929A3 (en) Imaging lens
BR112015022073A2 (en) automated organization for cell sorting
IN2014DN08394A (en)
EP2667210A3 (en) Apparatus for testing thyristor valve
EP3775706A4 (en) Medical residential and laboratory uses of purified air
EP2775162A3 (en) Composite bead plate and an air spring using the same
CA2902484C (en) Lateral flow assay with test strip retainer
WO2015009734A3 (en) Assays for antimicrobial activity and applications thereof
EP2998026A3 (en) Collector architecture layout design
EP2778527A3 (en) Gas flow control device for a gas stove
MX2017005470A (en) Malaria detection.
EP2574937A3 (en) Fast AC voltage detector
WO2014023984A3 (en) Method for the direct detection of mycobacterium tuberculosis
EP3293254A3 (en) Point of care assays to detect the status of tuberculosis infection
WO2014179737A3 (en) Assays and methods of treatment relating to vitamin d insufficiency
EP2557407A3 (en) Pressure sensor
WO2016029094A8 (en) Specimen conditioning and imaging system
EP2519080A3 (en) Illuminating apparatus and method thereof
WO2015061610A3 (en) Human t cell line assay for evaluating the immunologic identity of glatiramer acetate preparations
WO2020069513A3 (en) Dianostic lighting device
RU2012113763A (en) UNSATURATED BLOCK-COPOLESTERSULPHONES
WO2016069612A3 (en) Biomarkers for early diagnosis and differentiation of mycobacterial infection
RU2011153126A (en) METHOD FOR SPECIFIC IDENTIFICATION OF TUBERCULOSIS MYCOBACTERIA IN PERSONS INFECTED WITH TUBERCULOSIS MYCOBACTERIA